Latest News
The spring 2016 edition of Alzheimer's Disease Research Review addresses the consequences of brain injury on Alzheimer’s disease, and the potential protective benefits of statins (cholesterol-lowering medications) in improving brain recovery after a concussion. Also read about BrightFocus Foundation's support of the Dementia Friendly America Campaign, meet Makoto Ishii, MD, PhD, who is investigating the complex interactions between body weight and Alzheimer’s disease, and much more.
BrightFocus Foundation today announced $11.7 million in promising new scientific research projects, its largest annual investment toward finding cures for Alzheimer’s disease, macular degeneration, and glaucoma.
CentraSight® by VisionCare Ophthalmic Technologies, Inc., today announced a partnership with leading non-profit, BrightFocus Foundation to further patient research and education for advanced age-related macular degeneration (AMD) through a direct-to-patient outreach and survey program.
The spring edition of our macular degeneration research newsletter explores new treatments that are on the horizon, what to expect when it comes to injections, and more.
Learn about research exploring the mechanisms of eye pressure regulation, which could lead to improved glaucoma treatments, five tips for using glaucoma eye drops, information about childhood glaucoma, and more in the winter edition of the winter edition of our glaucoma newsletter.
Time magazine recently described a “cocktail” approach to fighting Alzheimer’s. BrightFocus-funded research supports this effort, which takes us closer to a cure.
BrightFocus Foundation joins with Montgomery County, MD Executive Isiah Leggett to announce the County’s commitment to Dementia Friendly America, a rapidly growing, national initiative to create communities that better recognize and help those affected with dementia, their families and care partners.
Stacy Pagos Haller, BrightFocus Foundation's President and CEO, urges the Food and Drug Administration to strongly support expanded use of neurodiagnostic tools to assess cognitive function.
Download the fall edition of our macular degeneration research newsletter and read about new treatments that are on the horizon, the latest research grants awarded for pioneering macular degeneration research, the first-ever bionic eye for patients with macular degeneration, and more.